Read + Share
Amedeo Smart
Independent Medical Education
Ciurea SO, Kongtim P, Srour S, Chen J, et al. Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. Am J Hematol 2024;99:890-899.PMID: 38444268
Email
LinkedIn
Facebook
Twitter
Privacy Policy